These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1073 related items for PubMed ID: 17540803

  • 21. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A, Maiz N, Garcia-Mandujano R, Penco JM, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [Abstract] [Full Text] [Related]

  • 22. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
    Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM, Hubel CA.
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253
    [Abstract] [Full Text] [Related]

  • 23. Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women.
    Forest JC, Thériault S, Massé J, Bujold E, Giguère Y.
    Clin Chem Lab Med; 2014 Aug; 52(8):1169-78. PubMed ID: 24535301
    [Abstract] [Full Text] [Related]

  • 24. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
    Kienast C, Moya W, Rodriguez O, Jijón A, Geipel A.
    J Matern Fetal Neonatal Med; 2016 Aug; 29(4):537-43. PubMed ID: 25708492
    [Abstract] [Full Text] [Related]

  • 25. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
    Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, CPEP Study Group.
    N Engl J Med; 2006 Sep 07; 355(10):992-1005. PubMed ID: 16957146
    [Abstract] [Full Text] [Related]

  • 26. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies.
    Dröge L, Herraìz I, Zeisler H, Schlembach D, Stepan H, Küssel L, Henrich W, Galindo A, Verlohren S.
    Ultrasound Obstet Gynecol; 2015 Mar 07; 45(3):286-93. PubMed ID: 25491901
    [Abstract] [Full Text] [Related]

  • 27. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
    Leaños-Miranda A, Campos-Galicia I, Berumen-Lechuga MG, Molina-Pérez CJ, García-Paleta Y, Isordia-Salas I, Ramírez-Valenzuela KL.
    J Rheumatol; 2015 Jul 07; 42(7):1141-9. PubMed ID: 25979720
    [Abstract] [Full Text] [Related]

  • 28. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.
    Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP, Gotsch F, Edwin S, Nien JK, Chaiworapongsa T, Mittal P, Mazaki-Tovi S, Than NG, Gomez R, Hassan SS.
    J Matern Fetal Neonatal Med; 2008 May 07; 21(5):279-87. PubMed ID: 18446652
    [Abstract] [Full Text] [Related]

  • 29. Prediction of preterm birth in women with fetal growth restriction - Is the weekly change in sFlt-1/PlGF ratio or PlGF levels useful?
    Hong J, Crawford K, Cavanagh E, Clifton V, Kumar S.
    Acta Obstet Gynecol Scand; 2024 Jun 07; 103(6):1112-1119. PubMed ID: 38483020
    [Abstract] [Full Text] [Related]

  • 30. High early pregnancy body mass index is associated with alterations in first- and second-trimester angiogenic biomarkers.
    Beck C, Allshouse A, Silver RM, Grobman WA, Simhan H, Haas D, Reddy UM, Blue NR.
    Am J Obstet Gynecol MFM; 2022 May 07; 4(3):100614. PubMed ID: 35283347
    [Abstract] [Full Text] [Related]

  • 31. The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia.
    Pinheiro CC, Rayol P, Gozzani L, Reis LM, Zampieri G, Dias CB, Woronik V.
    Prenat Diagn; 2014 Nov 07; 34(11):1084-92. PubMed ID: 24916790
    [Abstract] [Full Text] [Related]

  • 32. Threshold of soluble fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onset of preeclampsia.
    Ohkuchi A, Hirashima C, Matsubara S, Takahashi K, Matsuda Y, Suzuki M.
    Hypertension; 2011 Nov 07; 58(5):859-66. PubMed ID: 21947468
    [Abstract] [Full Text] [Related]

  • 33. The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia.
    Cui L, Shu C, Liu Z, Tong W, Cui M, Wei C, Tang JJ, Liu X, Hu J, Jiang J, He J, Zhang DY, Ye F, Li Y.
    Pregnancy Hypertens; 2018 Jul 07; 13():127-132. PubMed ID: 30177039
    [Abstract] [Full Text] [Related]

  • 34. Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia.
    Rana S, Hacker MR, Modest AM, Salahuddin S, Lim KH, Verlohren S, Perschel FH, Karumanchi SA.
    Hypertension; 2012 Aug 07; 60(2):451-8. PubMed ID: 22753210
    [Abstract] [Full Text] [Related]

  • 35. Prediction of preterm birth in growth-restricted and appropriate-for-gestational-age infants using maternal PlGF and the sFlt-1/PlGF ratio-A prospective study.
    Hong J, Crawford K, Cavanagh E, da Silva Costa F, Kumar S.
    BJOG; 2024 Jul 07; 131(8):1089-1101. PubMed ID: 38196326
    [Abstract] [Full Text] [Related]

  • 36. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
    Lim JH, Kim SY, Park SY, Yang JH, Kim MY, Ryu HM.
    Obstet Gynecol; 2008 Jun 07; 111(6):1403-9. PubMed ID: 18515525
    [Abstract] [Full Text] [Related]

  • 37. Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.
    Chaiworapongsa T, Romero R, Korzeniewski SJ, Kusanovic JP, Soto E, Lam J, Dong Z, Than NG, Yeo L, Hernandez-Andrade E, Conde-Agudelo A, Hassan SS.
    Am J Obstet Gynecol; 2013 Apr 07; 208(4):287.e1-287.e15. PubMed ID: 23333542
    [Abstract] [Full Text] [Related]

  • 38. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
    Triunfo S, Crovetto F, Crispi F, Rodriguez-Sureda V, Dominguez C, Nadal A, Peguero A, Gratacos E, Figueras F.
    Placenta; 2016 Jun 07; 42():44-50. PubMed ID: 27238713
    [Abstract] [Full Text] [Related]

  • 39. Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers.
    Tsao PN, Wei SC, Su YN, Chou HC, Chen CY, Hsieh WS.
    Pediatrics; 2005 Aug 07; 116(2):468-72. PubMed ID: 16061605
    [Abstract] [Full Text] [Related]

  • 40. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
    Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J, Karumanchi SA.
    J Clin Endocrinol Metab; 2004 Feb 07; 89(2):770-5. PubMed ID: 14764795
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.